References

Aebersold, R., and M. Mann. 2003. Mass spectrometry-based proteomics. Nature 422(6928):198-207.

Ahn, N.S., H. Hu, J.S. Park, J.S. Park, J.S. Kim, S. An, G. Kong, O.I. Aruoma, Y.S. Lee, and K.S. Kang. 2005. Molecular mechanisms of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced inverted U-shaped dose responsiveness in anchorage independent growth and cell proliferation of human breast epithelial cells with stem cell characteristics. Mutat. Res. 579(1-2):189-199.

AHS (Agricultural Health Study). 2006. Agricultural Health Study [online]. Available: http://www.aghealth.org/ [accessed Aug. 24, 2006].

Akutsu, T., S. Miyano, and S. Kuhara. 2000. Algorithms for identifying Boolean networks and related biological networks based on matrix multiplication and finger-print function. J. Comput. Biol. 7(3-4):331-343.

Alban, A., S.O. David, L. Bjorkesten, C. Andersson, E. Sloge, S. Lewis, and I. Currie. 2003. A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3(1):36-44.

Alexander, J., R. Reistad, S. Hegstad, H. Frandsen, K. Ingebrigtsen, J.E. Paulsen, and G. Becher. 2002. Biomarkers of exposure to heterocyclic amines: Approaches to improve the exposure assessment. Food Chem. Toxicol. 40(8):1131-1137.

Allen, A.L. 1997. Genetic privacy: Emerging concepts and values. Pp. 31-59 in Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era, M.A. Rothstein, ed. New Haven: Yale University Press.

Allen, E.E., J.S. Fetrow, L.W. Daniel, S.J. Thomas, and D.J. John. 2006. Algebraic dependency models of protein signal transduction networks from time-series data. J. Theor. Biol. 238(2):317-330.

Ames, R.G., S.K. Brown, D.C. Mengle, E. Kahn, J.W. Stratton, and R.J. Jackson. 1989. Cholinesterase activity depression among California agricultural pesticide applicators. Am. J. Ind. Med. 15(2):143-150.

Amin, R.P., A.E. Vickers, F. Sistare, K.L. Thompson, R.J. Roman, M. Lawton, J. Kramer, H.K. Hamadeh, J. Collins, S. Grissom, L. Bennett, C.J. Tucker, S. Wild, C. Kind, V. Oreffo, J.W. Davis II, S. Curtiss, J.M. Naciff, M. Cunningham, R. Tennant, J. Stevens, B. Car, T.A. Bertram, and C.A. Afshari. 2004. Identification of putative gene based markers of renal toxicity. Environ. Health Perspect. 112(4):465-479.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 213
References Aebersold, R., and M. Mann. 2003. Mass spectrometry-based proteomics. Nature 422(6928):198-207. Ahn, N.S., H. Hu, J.S. Park, J.S. Park, J.S. Kim, S. An, G. Kong, O.I. Aruoma, Y.S. Lee, and K.S. Kang. 2005. Molecular mechanisms of the 2,3,7,8-tetrachlorodibenzo-p- dioxin-induced inverted U-shaped dose responsiveness in anchorage independent growth and cell proliferation of human breast epithelial cells with stem cell charac- teristics. Mutat. Res. 579(1-2):189-199. AHS (Agricultural Health Study). 2006. Agricultural Health Study [online]. Available: http://www.aghealth.org/ [accessed Aug. 24, 2006]. Akutsu, T., S. Miyano, and S. Kuhara. 2000. Algorithms for identifying Boolean net- works and related biological networks based on matrix multiplication and finger- print function. J. Comput. Biol. 7(3-4):331-343. Alban, A., S.O. David, L. Bjorkesten, C. Andersson, E. Sloge, S. Lewis, and I. Currie. 2003. A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3(1):36-44. Alexander, J., R. Reistad, S. Hegstad, H. Frandsen, K. Ingebrigtsen, J.E. Paulsen, and G. Becher. 2002. Biomarkers of exposure to heterocyclic amines: Approaches to im- prove the exposure assessment. Food Chem. Toxicol. 40(8):1131-1137. Allen, A.L. 1997. Genetic privacy: Emerging concepts and values. Pp. 31-59 in Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era, M.A. Rothstein, ed. New Haven: Yale University Press. Allen, E.E., J.S. Fetrow, L.W. Daniel, S.J. Thomas, and D.J. John. 2006. Algebraic de- pendency models of protein signal transduction networks from time-series data. J. Theor. Biol. 238(2):317-330. Ames, R.G., S.K. Brown, D.C. Mengle, E. Kahn, J.W. Stratton, and R.J. Jackson. 1989. Cholinesterase activity depression among California agricultural pesticide applica- tors. Am. J. Ind. Med. 15(2):143-150. Amin, R.P., A.E. Vickers, F. Sistare, K.L. Thompson, R.J. Roman, M. Lawton, J. Kramer, H.K. Hamadeh, J. Collins, S. Grissom, L. Bennett, C.J. Tucker, S. Wild, C. Kind, V. Oreffo, J.W. Davis II, S. Curtiss, J.M. Naciff, M. Cunningham, R. Tennant, J. Stevens, B. Car, T.A. Bertram, and C.A. Afshari. 2004. Identification of putative gene based markers of renal toxicity. Environ. Health Perspect. 112(4):465-479. 213

OCR for page 213
214 Applications of Toxicogenomic Technologies Anazawa, Y., H. Nakagawa, M. Furihara, S. Ashida, K. Tamura, H. Yoshioka, T. Shuin, T. Fujioka, T. Katagiri, and Y. Nakamura. 2005. PCOTH, a novel gene overex- pressed in prostate cancers, promotes prostate cancer cell growth through phos- phorylation of oncoprotein TAF-Ibeta/SET. Cancer Res. 65(11):4578-4586. Andersen, M.E., H.J. Clewell III, M.L. Gargas, F.A. Smith, and R.H. Reitz. 1987. Physiologically based pharmacokinetics and the risk assessment process for me- thylene chloride. Toxicol. Appl. Pharmacol. 87(2):185-205. Anderson, N.L., and N.G. Anderson. 2002. The human plasma proteome: History, char- acter, and diagnostic prospects. Mol. Cell Proteomics 1(11):845-867. Anderson, N.L., N.G. Anderson, L.R. Haines, D.B. Hardie, R.W. Olafson, and T.W. Pearson. 2004. Mass spectrometric quantitation of peptides and proteins using Sta- ble Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J. Pro- teome Res. 3(2):235-244. Ando, Y., and Y. Hayashizaki. 2006. Restriction landmark genomic scanning. Nat. Pro- toc. 1(6):2774-2783. Andrew, A.S., A.J. Warren, A. Barchowsky, K.A. Temple, L. Klei, N.V. Soucy, K.A. O'Hara, and J.W. Hamilton. 2003. Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ. Health Perspect. 111(6):825-835. Andrews, L.B. 2005. Harnessing the benefits of biobanks. J. Law Med. Ethics 33(1):22- 30. Antoniadis, A., S. Lambert-Lacroix, and F. Leblanc. 2003. Effective dimension reduction methods for tumor classification using gene expression data. Bioinformatics 19(5):563-570. Anway, M.D., A.S. Cupp, M. Uzumcu, and M.K. Skinner. 2005. Epigenetic transgenera- tional actions of endocrine disruptors and male fertility. Science 308(5727):1466- 1469. Arbour, N.C., E. Lorenz, B.C. Schutte, J. Zabner, J.N. Kline, M. Jones, K. Frees, J.L. Watt, and D.A. Schwartz. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25(2):187-191. Ausness, R.C. 2002. Will more aggressive marketing practices lead to greater tort liabil- ity for prescription drug manufacturers? Wake Forest Law Rev. 37(1):97-139. Azmi, J., J.L. Griffin, H. Antti, R.F. Shore, E. Johansson, J.K. Nicholson, and E. Holmes. 2002. Metabolic trajectory characterisation of xenobiotic-induced hepatotoxic le- sions using statistical batch processing of NMR data. Analyst 127(2):271-276. Bae, D.S., W.H. Hanneman, R.S. Yang, and J.A. Campain. 2002. Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treat- ment in human keratinocytes: Application of cDNA microarray technology. Envi- ron. Health Perspect. 110(Suppl. 6):931-941. Baggerly, K.A., K.R. Coombes, K.R. Hess, D.N. Stivers, L.V. Abruzzo, and W. Zhang. 2001. Identifying differentially expressed genes in cDNA microarray experiments. J. Comput. Biol. 8(6):639-659. Baggerly, K.A., J.S. Morris, and K.R. Coombes. 2004. Reproducibility of SELDI-TOF protein patterns in serum: Comparing datasets from different experiments. Bioin- formatics 20(5):777-785. Baggerly, K.A., J.S. Morris, S.R. Edmonson, and K.R. Coombes. 2005. Signal in noise: Evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J. Natl. Cancer Inst. 97(4):307-309. Bailey, W.J., and R. Ulrich. 2004. Molecular profiling approaches for identifying novel biomarkers. Expert. Opin. Drug Saf. 3(2):137-151.

OCR for page 213
215 References Baker, V.A., H.M. Harries, J.F. Waring, C.M. Duggan, H.A. Ni, R.A. Jolly, L.W. Yoon, A.T. De Souza, J.E. Schmid, R.H. Brown, R.G. Ulrich, and J.C. Rockett. 2004. Clofibrate-induced gene expression changes in rat liver: A cross-laboratory analy- sis using membrane cDNA arrays. Environ. Health Perspect. 112(4):428-438. Ball, C.A, G. Sherlock, H. Parkinson, P. Rocca-Sera, C. Brooksbank, H.C. Causton, D. Cavalieri, T. Gaasterland, P. Hingamp, F. Holstege, M. Ringwald, P. Spellman, C.J. Stoeckert, Jr., J.E. Stewart, R. Taylor, A. Brazma, and J. Quackenbush. 2002a. Standards for microarray data [letter]. Science 298(5593):539. Ball, C.A., G. Sherlock, H. Parkinson, P. Rocca-Sera, C. Brooksbank, H.C. Causton, D. Cavalieri, T. Gaasterland, P. Hingamp, F. Holstege, M. Ringwald, P. Spellman, C.J. Stoeckert, Jr., J.E. Stewart, R. Taylor, A. Brazma, and J. Quackenbush. 2002b. The underlying principles of scientific publication [review]. Bioinformatics 18(11):1409. Ball, C.A., A. Brazma, H.C. Causton, S. Chervitz, R. Edgar, P. Hingamp, J.C. Matese, H. Parkinson, J. Quackenbush, M. Ringwald, S.A. Sansone, G. Sherlock, P. Spellman, C. Stoeckert, Y. Tateno, R. Taylor, J. White, and N. Winegarden. (MGED Soci- ety). 2004a. Standards for microarray data: An open letter. Environ. Health Per- spect. 112(12):A666-A667. Ball, C.A., A. Brazma, H. Causton, S. Chervitz, R. Edgar, P. Hingamp, J.C. Matese, C. Icahn, H. Parkinson, J. Quackenbush, M. Ringwald, S.A. Sansone, G. Sherlock, P. Spellman, C. Stoeckert, Y. Tateno, R. Taylor, J. White, and N. Winegarden. (MGED Society). 2004b. An open letter on microarray data from the MGED Soci- ety. Microbiology 150(Pt 11):3522-3524. Bammler, T., R.P. Beyer, S. Bhattacharya, G.A. Boorman, A. Boyles, B.U. Bradford, R.E. Bumgarner, P.R. Bushel, K. Chaturvedi, D. Choi, M.L. Cunningham, S. Deng, H.K. Dressman, R.D. Fannin, F.M. Farin, J.H. Freedman, R.C. Fry, A. Harper, M.C. Humble, P. Hurban, T.J. Kavanagh, W.K. Kaufmann, K.F. Kerr, L. Jing, J.A. Lapidus, M.R. Lasarev, J. Li, Y.J. Li, E.K. Lobenhofer, X. Lu, R.L. Malek, S. Milton, S.R. Nagalla, J.P. O'Malley, V.S. Palmer, P. Pattee, R.S. Paules, C.M. Perou, K. Phillips, L.X. Qin, Y. Qiu, S.D. Quigley, M. Rodland, I. Rusyn, L.D. Samson, D.A. Schwartz, Y. Shi, J.L. Shin, S.O. Sieber, S. Slifer, M.C. Speer, P.S. Spencer, D.I. Sproles, J.A. Swenberg, W.A. Suk, R.C. Sullivan, R. Tian, R.W. Tennant, S.A. Todd, C.J. Tucker, B. Van Houten, B.K. Weis, S. Xuan, and H. Zarbl. 2005. Standardizing global gene expression analysis between laboratories and across platforms. Nat. Methods 2(5):351-356. Bandara, L.R., M.D. Kelly, E.A. Lock, and S. Kennedy. 2003. A correlation between a proteomic evaluation and conventional measurements in the assessment of renal proximal tubular toxicity. Toxicol. Sci. 73(1):195-206. Baram, M. 2001. Genetic testing for susceptibility to disease from exposure to toxic chemicals: Implications for public and worker health policies. Jurimetrics 41(2):165-176. Barczak, A., M.W. Rodriguez, K. Hanspers, L.L. Koth, T.C. Tai, B.M. Bolstad, T.P. Speed, and D.J. Erle. 2003. Spotted long oligonucleotide arrays for human gene expression analysis. Genome Res. 13(7):1775-1785. Battuello, K., R. Fenske, C. Furlong, M. Austin, and W. Burke. 2002. CEEH ILSI Core Case Study 1: Genetic Variation in PON1 and Pesticide Sensitivity: Implications for Workplace Screening. March 13, 2002 [online]. Available: http://depts. washington.edu/ceeh/issues/PON.pdf [accessed March 6, 2006].

OCR for page 213
216 Applications of Toxicogenomic Technologies BDW Group (Biomarkers Definitions Working Group). 2001. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69(3):89-95. Beckwith-Hall, B.M., J.K. Nicholson, A.W. Nicholls, P.J. Foxall, J.C. Lindon, S.C. Connor, M. Abdi, J. Connelly, and E. Holmes. 1998. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol. 11(4):260-272. Begley, T.J., and L.D. Samson. 2004. Network responses to DNA damaging agents. DNA Repair (Amst). 3(8-9):1123-1132. Begley, T.J., A.S. Rosenbach, T. Ideker, and L.D. Samson. 2002. Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and in- teractome mapping. Mol. Cancer Res. 1(2):103-112. Begley, T.J., A.S. Rosenbach, T. Ideker, and L.D. Samson. 2004. Hot spots for modulat- ing toxicity identified by genomic phenotyping and localization mapping. Mol. Cell. 16(1):117-125. Bellamy, R., C. Ruwende, T. Corrah, K.P. McAdam, H.C. Whittle, and A.V. Hill. 1998. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Afri- cans. N. Engl. J. Med. 338(10):640-644. Bellamy, R., N. Beyers, K.P. McAdam, C. Ruwende, R. Gie, P. Samaai, D. Bester, M. Meyer, T. Corrah, M. Collin, D.R. Camidge, D. Wilkinson, E. Hoal-Van Helden, H.C. Whittle, W. Amos, P. van Helden, and A.V. Hill. 2000. Genetic susceptibility to tuberculosis in Africans: A genome-wide scan. Proc. Natl. Acad. Sci. USA 97(14):8005-8009. Berra, E., A. Ginouves, and J. Pouyssegur. 2006. The hypoxia-inducible-factor hydroxy- lases bring fresh air into hypoxia signalling. EMBO Rep. 7(1):41-45. Bibikova, M., Z. Lin, L. Zhou, E. Chudin, E.W. Garcia, B. Wu, D. Doucet, N.J. Thomas, Y. Wang, E. Vollmer, T. Goldmann, C. Seifart, W. Jiang, D.L. Barker, M.S. Chee, J. Floros, and J.B. Fan. 2006. High-throughput DNA methylation profiling using universal bead arrays. Genome Res. 16(3):383-393. Birnbaum, L.S., and S.E. Fenton. 2003. Cancer and developmental exposure to endocrine disruptors. Environ. Health Perspect. 111(4):389-394. Bjornsson, H.T., M.D. Fallin, and A.P. Feinberg. 2004. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 20(8):350-358. Blackwell, J.M., C.H. Barton, J.K. White, S. Searle, A.M. Baker, H. Williams, and M.A. Shaw. 1995. Genomic organization and sequence of the human NRAMP gene: Identification and mapping of a promoter region polymorphism. Mol. Med. 1(2):194-205. Blondell, J. 1999. Review of Poison Control Center Data for Residential Exposures to Organophosphate Pesticides, 1993-1996. Memorandum to Dennis Utterback, Team Leader, Organophosphate Residential Team, from Jerome Blondell, Health Statistician, Chemistry and Exposure Branch 2 Health Effects Division, Office of Prevention, Pesticides and Toxic Substances, U.S. Environmental Protection Agency, Washington, DC. February 11, 1999 [online]. Available: http://www.epa. gov/pesticides/op/disulfoton/ppcdata.pdf [accessed May 8, 2007]. Bloom, G., I.V. Yang, D. Boulware, K.Y. Kwong, D. Coppola, S. Eschrich, J. Quackenbush, and T.J. Yeatman. 2004. Multi-platform, multi-site, microarray- based human tumor classification. Am. J. Pathol. 164(1):9-16. Boess, F., M. Kamber, S. Romer, R. Gasser, D. Muller, S. Albertini, and L. Suter. 2003. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver

OCR for page 213
217 References slices compared to the in vivo liver gene expression in rats: Possible implications for toxicogenomics use of in vitro systems. Toxicol. Sci. 73(2):386-402. Bogaerts, J., F. Cardoso, M. Buyse, S. Braga, S. Loi, J.A. Harrison, J. Bines, S. Mook, N. Decker, P. Ravdin, P. Therasse, E. Rutgers, L.J. van 't Veer, and M. Piccart. 2006. Gene signature evaluation as a prognostic tool: Challenges in the design of the MINDACT trial. Nat. Clin. Pract. Oncol. 3(10):540-551. Bollard, M.E., J. Xu, W. Purcell, J.L. Griffin, C. Quirk, E. Holmes, and J.K. Nicholson. 2002. Metabolic profiling of the effects of D-galactosamine in liver spheroids us- ing (1)H NMR and MAS-NMR spectroscopy. Chem. Res. Toxicol. 15(11):1351- 1359. Bollard, M.E., H.C. Keun, O. Beckonert, T.M. Ebbels, H. Antti, A.W. Nicholls, J.P. Shockcor, G.H. Cantor, G. Stevens, J.C. Lindon, E. Holmes, and J.K. Nicholson. 2005. Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicol. Appl. Pharmacol. 204(2):135-151. Bombail, V., J.G. Moggs, and G. Orphanides. 2004. Perturbation of epigenetic status by toxicants. Toxicol. Lett. 149(1-3):51-58. Bookman, E.B., A.A. Langehorne, J.H. Eckfeldt, K.C. Glass, G.P. Jarvik, M. Klag, G. Koski, A. Motulsky, B. Wilfond, T.A. Manolio, R.R. Fabsitz, and R.V. Luepker. 2006. Reporting genetic results in research studies: Summary and recommenda- tions of an NHLBI working group. Am. J. Med. Genet. A 140(10): 1033-1040. Boulesteix, A.L., G. Tutz, and K. Strimmer. 2003. A CART-based approach to discover emerging patterns in microarray data. Bioinformatics 19(18):2465-2472. Boverhof, D.R., K.C. Fertuck, L.D. Burgoon, J.E. Eckel, C. Gennings, and T.R. Zacharewski. 2004. Temporal- and dose-dependent hepatic gene expression changes in immature ovariectomized mice following exposure to ethynyl estradiol. Carcinogenesis. 25(7):1277-1291. Boverhof, D.R., L.D. Burgoon, C. Tashiro, B. Chittim, J.R. Harkema, D.B. Jump, and T.R. Zacharewski. 2005. Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity. Toxi- col. Sci. 85(2):1048-1063. Bradshaw, R.A. 2005a. DRAFT Proposed Publication Guidelines for the Analysis and Documentation of Peptide and Protein Identifications. July 14, 2005 [online]. Available: http://www.mcponline.org/misc/ParisReport.shtml [accessed Nov. 8, 2005]. Bradshaw, R.A. 2005b. Revised draft guidelines for proteomic data publication. Mol.Cell Proteomics. 4(9):1223-1225. Branca, A.F., and A. Peck. 2004. Toxicogenomics: A Brenchmark Assessment of Current Practices and Future Expectations. Cambridge Healthtech Advisors, Cambridge, MA. Brazma, A., P. Hingamp, J. Quackenbush, G. Sherlock, P. Spellman, C. Stoeckert, J. Aach, W. Ansorge, C.A. Ball, H.C. Causton, T. Gaasterland, P. Glenisson, F.C. Holstege, I.F. Kim, V. Markowitz, J.C. Matese, H. Parkinson, A. Robinson, U. Sarkans, S. Schulze-Kremer, J. Stewart, R. Taylor, J. Vilo, and M. Vingron. 2001. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29(4):365-371. Brazma, A., H. Parkinson, U. Sarkans, M. Shojatalab, J. Vilo, N. Abeygunawardena, E. Holloway, M. Kapushesky, P. Kemmeren, G.G. Lara, A. Oezcimen, P. Rocca- Serra, and S.A. Sansone. 2003. ArrayExpress: A public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 31(1):68-71.

OCR for page 213
218 Applications of Toxicogenomic Technologies Breyer, S.G. 1995. Breaking the Vicious Cycle: Toward Effective Risk Regulation. Cam- bridge, MA: Harvard University Press. Brown, M.P., W.N. Grundy, D. Lin, N. Cristianini, C.W. Sugnet, T.S. Furey, M. Ares, Jr., and D. Haussler. 2000. Knowledge-based analysis of microarray gene expres- sion data by using support vector machines. Proc. Natl. Acad. Sci. USA 97(1):262- 267. Brown, S.C., G. Kruppa, and J.L. Dasseux. 2005. Metabolomics applications of FT-ICR mass spectrometry. Mass Spectrom. Rev. 24(2):223-231. Budinsky, R.A. 2005. A summary of the 2005 winter toxicology forum session on dioxin toxic equivalency factors. Workshop report. Regul. Toxicol. Pharmacol. 43(3): 324-326. Burke, W., L. Acheson, J. Botkin, K. Bridges, A. Davis, J. Evans, J. Frias, J. Hanson, N. Kahn, R. Kahn, D. Lanier, L.E. Pinsky, N. Press, M.A. Lloyd-Puryear, E. Rich, N. Stevens, E. Thomson, S. Wartman, and M. Wilson. 2002. Genetics in primary care: A USA faculty development initiative. Community Genet. 5(2):138-146. Bus, J.S., R.A. Canady, T.K. Collier, W. Owens, S.D. Pettit, N.L. Scholz, and A.C. Street. 2007. The extension of molecular and computational information to risk as- sessment and regulatory decision making. Pp. 151-177 in Genomic Approaches for Cross-Species Extrapolation in Toxicology, W.H. Benson, and R.T. Di Guiulio, eds. Pensacola, FL: SETAC Press. Butcher, E.C. 2005. Can cell systems biology rescue drug discovery? Nat. Rev. Drug Discov. 4(6):461-467. Butte, A.J., and I.S. Kohane. 1999. Unsupervised knowledge discovery in medical data- bases using relevance networks. Proc. AMIA Symp. (1999):711-715. Buyse, M., S. Loi, L. van't Veer, G. Viale, M. Delorenzi, A.M. Glas, M.S. d'Assignies, J. Bergh, R. Lidereau, P. Ellis, A. Harris, J. Bogaerts, P. Therasse, A. Floore, M. Amakrane, F. Piette, E. Rutgers, C. Sotiriou, F. Cardoso, and M.J. Piccart. 2006. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J. Natl. Cancer Inst. 98(17):1183-1192. Carruth, R.S., and B.D. Goldstein. 2001. Relative risk greater than two in proof of causa- tion in toxic tort litigation. Jurimetrics 41(2):195-210. Carter, M.G., T. Hamatani, A.A. Sharov, C.E. Carmack, Y. Qian, K. Aiba, N.T. Ko, D.B. Dudekula, P.M. Brzoska, S.S. Hwang, and M.S. Ko. 2003. In situ-synthesized novel microarray optimized for mouse stem cell and early developmental expres- sion profiling. Genome Res. 13(5):1011-1021. Castoldi, M, S. Schmidt, V. Benes, M. Noerholm, A.E. Kulozik, M.W. Hentze, and M.U. Muckenthaler. 2006. A sensitive array for microRNA expression profiling (mi- Chip) based on locked nucleic acids (LNA). RNA 12(5):913-920. CEBS (Chemical Effects in Biological Systems). 2007. Chemical Effects in Biological Systems. National Institute of Environmental Health Sciences, U.S. National Institutes of Health [online]. Available: http://cebs.niehs.nih.gov/cebs-browser/ cebsHome.do [accessed May 30, 2007]. Chadwick, R.F. 2004. The right not to know: A challenge for accurate self-assessment. Philos. Psychiatry Psychology 11(4):299-301. Chan, E.Y. 2005. Advances in sequencing technology. Mutat Res. 573(1-2):13-40. Chan, E.Y., N.M. Goncalves, R.A. Haeusler, A.J. Hatch, J.W. Larson, A.M. Maletta, G.R. Yantz, E.D. Carstea, M. Fuchs, G.G. Wong, S.R. Gullans, and R. Gilmanshin. 2004. DNA mapping using microfluidic stretching and single- molecule detection of fluorescent site-specific tags. Genome Res. 14(6):1137- 1146.

OCR for page 213
219 References Chaurand, P., M. Stoeckli, and R.M. Caprioli. 1999. Direct profiling of proteins in bio- logical tissue sections by MALDI mass spectrometry. Anal. Chem. 71(23):5263- 5270. Chellappan, S.P. 2001. HOG on the promoter: Regulation of the osmotic stress response. Sci. STKE (93):PE1 Cheung, S.T., X. Chen, X.Y. Guan, S.Y. Wong, L.S. Tai, I.O. Ng, S. So, and S.T. Fan. 2002. Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. Cancer Res. 62(16):4711-4721. Cheung, V.G., L.K. Conlin, T.M. Weber, M. Arcaro, K.Y. Jen, M. Morley, and R.S. Spielman. 2003. Natural variation in human gene expression assessed in lym- phoblastoid cells. Nat Genet. 33(3):422-425. Christiani, D.C., R.R. Sharp, G.W. Collman, and W.A. Suk. 2001. Applying genomic technologies in environmental health research: Challenges and opportunities. J. Occup. Environ. Med. 43(6):526-533. Chu, T.M., S. Deng, R. Wolfinger, R.S. Paules, and H.K. Hamadeh. 2004. Cross-site comparison of gene expression data reveals high similarity. Environ. Health Per- spect. 112(4):449-455. Churchill, G.A. 2002. Fundamentals of experimental design for cDNA microarrays. Nat. Genet. 32(Suppl.):490-495. Churchill, G.A., D.C. Airey, H. Allayee, J.M. Angel, A.D. Attie, J. Beatty, W.D. Beavis, J.K. Belknap, B. Bennett, W. Berrettini, A. Bleich, M. Bogue, K.W. Broman, K.J. Buck, E. Buckler, M. Burmeister, E.J. Chesler, J.M. Cheverud, S. Clapcote, M.N. Cook, R.D. Cox, J.C. Crabbe, W.E. Crusio, A. Darvasi, C.F. Deschepper, R.W. Doerge, C.R. Farber, J. Forejt, D. Gaile, S.J. Garlow, H. Geiger, H. Gershenfeld, T. Gordon, J. Gu, W. Gu, G. de Haan, N.L. Hayes, C. Heller, H. Himmelbauer, R. Hitzemann, K. Hunter, H.C. Hsu, F.A. Iraqi, B. Ivandic, H.J. Jacob, R.C. Jansen, K.J. Jepsen, D.K. Johnson, T.E. Johnson, G. Kempermann, C. Kendziorski, M. Kotb, R.F. Kooy, B. Llamas, F. Lammert, J.M. Lassalle, P.R. Lowenstein, L. Lu, A. Lusis, K.F. Manly, R. Marcucio, D. Matthews, J.F. Medrano, D.R. Miller, G. Mittleman, B.A. Mock, J.S. Mogil, X. Montagutelli, G. Morahan, D.G. Morris, R. Mott, J.H. Nadeau, H. Nagase, R.S. Nowakowski, B.F. O'Hara, A.V. Osadchuk, G.P. Page, B. Paigen, K. Paigen, A.A. Palmer, H.J. Pan, L. Peltonen-Palotie, J. Peirce, D. Pomp, M. Pravenec, D.R. Prows, Z. Qi, R.H. Reeves, J. Roder, G.D. Rosen, E.E. Schadt, L.C. Schalkwyk, Z. Seltzer, K. Shimomura, S. Shou, M.J. Sillanpaa, L.D. Siracusa, H.W. Snoeck, J.L. Spearow, K. Svenson, L.M. Tarantino, D. Threadgill, L.A. Toth, W. Valdar, F.P. de Villena, C. Warden, S. Whatley, R.W. Williams, T. Wiltshire, N. Yi, D. Zhang, M. Zhang, F. Zou, Complex Trait Consortium. 2004. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat. Genet. 36(11):1133-1137. Ciesielski, S., D.P. Loomis, S.R. Mims, and A. Auer. 1994. Pesticide exposures, choli- nesterase depression, and symptoms among North Carolina migrant farmworkers. Am. J. Public Health 84(3):446-451. Clayton, E.W. 2003. Ethical, legal, and social implications of genomic medicine. N. Engl. J. Med. 349(6):562-569. Clayton, E.W. 2005. Informed consent and biobanks. J. Law Med. Ethics 33(1):15-21. Clifford, R.J., M.N. Edmonson, C. Nguyen, and K.H. Buetow. 2004. Large-scale analysis of non-synonymous coding region single nucleotide polymorphisms. Bioinformat- ics 20(7):1006-1014.

OCR for page 213
220 Applications of Toxicogenomic Technologies Coen, M., E.M. Lenz, J.K. Nicholson, I.D. Wilson, F. Pognan, and J.C. Lindon. 2003. An integrated metabonomic investigation of acetaminophen toxicity in the mouse us- ing NMR spectroscopy. Chem. Res. Toxicol. 16(3):295-303. Coen, M., S.U. Ruepp, J.C. Lindon, J.K. Nicholson, F. Pognan, E.M. Lenz, and I.D. Wilson. 2004. Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse. J. Pharm. Biomed. Anal. 35(1):93-105. Cohen, S.D., N.R. Pumford, E.A. Khairallah, K. Boekelheide, L.R. Pohl, H.R. Amouzadeh, and J.A. Hinson. 1997. Selective protein covalent binding and target organ toxicity. Toxicol. Appl. Pharmacol. 143(1):1-12. Colburn, W.A. 2003. Biomarkers in drug discovery and development: From target identi- fication through drug marketing. J. Clin. Pharmacol. 43(4):329-341. Cole, T.B., B.J. Walter, D.M. Shih, A.D. Tward, A.J. Lusis, C. Timchalk, R.J. Richter, L.G. Costa, and C.E. Furlong. 2005. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenet. Genomics. 15(8):589-598. Conrads, T.P., B.L. Hood, H.J. Issaq, and T.D. Veenstra. 2004. Proteomic patterns as a diagnostic tool for early-stage cancer: A review of its progress to a clinically rele- vant tool. Mol. Diagn. 8(2):77-85. Cook, D.N., S. Wang, Y. Wang, G.P. Howles, G.S. Whitehead, K.G. Berman, T.D. Church, B.C. Frank, R.M. Gaspard, Y. Yu, J. Quackenbush, and D.A. Schwartz. 2004. Genetic regulation of endotoxin-induced airway disease. Genomics 83(6):961-969. Coon, J. J., B. Ueberheide, J.E. Syka, D.D. Dryhurst, J. Ausio, J. Shabanowitz, and D.F. Hunt. 2005. Protein identification using sequential ion/ion reactions and tandem mass spectrometry. Proc. Natl. Acad. Sci. U.S.A 102(27):9463-9468. Corvi, R., H.J. Ahr, S. Albertini, D.H. Blakey, L. Clerici, S. Coecke, G.R. Douglas, L. Gribaldo, J.P. Groten, B. Haase, K. Hamernik, T. Hartung, T. Inoue, I. Indans, D. Maurici, G. Orphanides, D. Rembges, S.A. Sansone, J.R. Snape, E. Toda, W. Tong, J.H. van Delft, B. Weis, and L.M. Schechtman. 2006. Validation of Toxico- genomics-Based Test Systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use. Environ. Health Perspect. 114(3):420-429. Cosma, G.N., P. Toniolo, D. Currie, B.S. Pasternack, and S.J. Garte. 1992. Expression of the CYP1A1 gene in peripheral lymphocytes as a marker of exposure to creosote in railroad workers. Cancer Epidemiol. Biomarkers Prev. 1(2):137-142. Craig, R., and R.C. Beavis. 2004. TANDEM: Matching proteins with tandem mass spec- tra. Bioinformatics 20(9):1466-1467. Craig, R., J.P. Cortens, and R.C. Beavis. 2004. Open source system for analyzing, vali- dating, and storing protein identification data. J. Proteome Res. 3(6):1234-1242. Cranor, C.F. 1997. Eggshell skulls and loss of hair from fright: Some moral and legal principles that protect susceptible subpopulations. Environ. Toxicol. Pharmacol. 4(3-4):239-245. Crespi, C.L., and V.P. Miller. 1999. The use of heterologously expressed drug metaboliz- ing enzymes--state of the art and prospects for the future. Pharmacol. Ther. 84(2):121-131. Crespi, C.L., B.W. Penman, D.T. Steimel, T. Smith, C.S. Yang, and T.R. Sutter. 1997. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: Substrate specificity with model substrates and promutagens. Mutagenesis 12(2):83-89.

OCR for page 213
221 References Cronin, M., K. Ghosh, F. Sistare, J. Quackenbush, V. Vilker, and C. O'Connell. 2004. Universal RNA reference materials for gene expression. Clin. Chem. 50(8):1464- 1471. Cupp, A.S., M. Uzumcu, H. Suzuki, K. Dirks, B. Phillips, and M.K. Skinner. 2003. Effect of transient embryonic in vivo exposure to the endocrine disruptor methoxychlor on embryonic and postnatal testis development. J. Androl. 24(5):736-745. Daston, G.P. 2004. Developmental toxicity evaluation of butylparaben in Sprague- Dawley rats. Birth Defects Res. B Dev. Reprod. Toxicol 71(4):296-302. Daston, G.P., and J.M. Naciff. 2005. Gene expression changes related to growth and differentiation in the fetal and juvenile reproductive system of the female rat: Evaluation of microarray results. Reprod. Toxicol. 19(3):381-394. Datta, A., A. Choudhary, M.L. Bittner, and E.R. Dougherty. 2004. External control in Markovian genetic regulatory networks: The imperfect information case. Bioin- formatics 20(6):924-930. De Sanctis, G.T., and J.M. Drazen. 1997. Genetics of native airway responsiveness in mice. Am. J. Respir. Crit. Care Med. 156(4 Pt 2):S82-S88. Deschênes, M., and C. Sallée. 2005. Accountability in population biobanking: Comparative approaches. J. Law Med. Ethics 33(1):40-53. Desiere, F., E.W. Deutsch, A.I. Nesvizhskii, P. Mallick, N.L. King, J.K. Eng, A. Aderem, R. Boyle, E. Brunner, S. Donohoe, N. Fausto, E. Hafen, L. Hood, M.G. Katze, K.A. Kennedy, F. Kregenow, H. Lee, B. Lin, D. Martin, J.A. Ranish, D.J. Rawlings, L.E. Samelson, Y. Shiio, J.D. Watts, B. Wollscheid, M.E. Wright, W. Yan, L. Yang, E.C. Yi, H. Zhang, and R. Aebersold. 2005. Integration with the human genome of peptide sequences obtained by high-throughput mass spec- trometry. Genome Biol. 6(1):R9. Desiere, F., E.W. Deutsch, N.L. King, A.I. Nesvizhskii, P. Mallick, J. Eng, S. Chen, J. Eddes, S.N. Loevenich, and R. Aebersold. 2006. The PeptideAtlas project. Nucleic Acids Res. 34:D655-D658. de Wildt, R.M., C.R. Mundy, B.D. Gorick, and I.M. Tomlinson. 2000. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat. Biotechnol. 18(9):989-994. DHHS (U.S. Department of Health and Human Services). 1997. Issues to Consider in the Research Use of Stored Data or Tissues. Office for Protection from Research Risks, U.S. Department of Health and Human Services [online]. Available: www.hhs.gov/ohrp/humansubjects/guidance/reposit.htm [accessed Nov. 10, 2005]. DHHS (U.S. Department of Health and Human Services). 2004. Guidance on Research Involving Coded Private Information or Biological Specimens. Office for Human Research Protections, U.S. Department of Health and Human Services [online]. Available: http://www.hhs.gov/ohrp/humansubjects/guidance/cdebiol.pdf [ac- cessed Nov. 10, 2005]. DHHS (U.S. Department of Health and Human Services). 2006. Medical Privacy – Na- tional Standards to Protect the Privacy of Personal Health Information. Office for Civil Rights – HIPAA, U.S. Department of Health and Human Services, Washing- ton, DC [online]. Available: http://www.hhs.gov/ocr/hipaa/ [accessed Aug. 24, 2006]. Diamandis, E.P. 2004. Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems. J. Natl. Cancer Inst. 96(5):353-356. Dickinson, D.A., G.R. Warnes, G. Quievryn, J. Messer, A. Zhitkovich, E. Rubitski, and J. Aubrecht. 2004. Differentiation of DNA reactive and non-reactive genotoxic mechanisms using gene expression profile analysis. Mutat. Res. 549(1-2):29-41.

OCR for page 213
222 Applications of Toxicogenomic Technologies Dobbin, K.K., and R.M. Simon. 2005. Sample size determination in microarray experi- ments for class comparison and prognostic classification. Biostat. 6(1):27-38. Dobbin, K.K., D.G. Beer, M. Meyerson, T.J. Yeatman, W.L. Gerald, J.W. Jacobson, B. Conley, K.H. Buetow, M. Heiskanen, R.M. Simon, J.D. Minna, L. Girard, D.E. Misek, J.M. Taylor, S. Hanash, K. Naoki, D.N. Hayes, C. Ladd-Acosta, S.A. Enkemann, A. Viale, and T.J. Giordano. 2005. Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin. Cancer Res. 11(2 Pt. 1):565-572. Doll, R., and R. Wakeford. 1997. Risk of childhood cancer from fetal irradiation. Br. J. Radiol. 70:130-139. Doniger, S.W., N. Salomonis, K.D. Dahlquist, K. Vranizan, S.C. Lawlor, and B.R. Conklin. 2003. MAPPFinder: Using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 4(1):R7. Dorne, J.L., K. Walton, W. Slob, and A.G. Renwick. 2002. Human variability in poly- morphic CYP2D6 metabolism: Is the kinetic default uncertainty factor adequate? Food Chem. Toxicol. 40(11):1633-1656. Dorne, J.L., K. Walton, and A.G. Renwick. 2005. Human variability in xenobiotic me- tabolism and pathway-related uncertainty factors for chemical risk assessment: A review. Food Chem. Toxicol. 43(2):203-216. Dudoit, S., R.C. Gentleman, and J. Quackenbush. 2003. Open source software for the analysis of microarray data. Biotechniques (Suppl.):45-51. EDF (Environmental Defense Fund). 1997. Toxic Ignorance: The Continuing Absence of Basic Health Testing for Top-Selling Chemicals in the United States. New York: Environmental Defense Fund. Edgar, R., M. Domrachev, and A.E. Lash. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30(1):207- 210. Ehrenberg, L., F. Granath, and M. Tornqvist. 1996. Macromolecule adducts as bio- markers of exposure to environmental mutagens in human populations. Environ. Health Perspect. 104(Suppl. 3):423-428. Eiseman, E., and S.B. Haga. 1999. Handbook of Human Tissue Sources: A National Re- source of Human Tissue Samples. Santa Monica, CA: RAND. Eisen, M.B., P.T. Spellman, P.O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95(25):14863-14868. Elias, J.E., W. Haas, B.K. Faherty, and S.P. Gygi. 2005. Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations. Nat. Meth- ods 2(9):667-675. Ellinger-Ziegelbauer, H., B. Stuart, B. Wahle, W. Bomann, and H.J. Ahr. 2004. Charac- teristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol. Sci. 77(1):19-34. Ellis, M., N. Davis, A. Coop, M. Liu, L. Schumaker, R.Y. Lee, R. Srikanchana, C.G. Russell, B. Singh, W.R. Miller, V. Stearns, M. Pennanen, T. Tsangaris, A. Gallagher, A. Liu, A. Zwart, D.F. Hayes, M.E. Lippman, Y. Wang, and R. Clarke. 2002. Development and validation of a method for using breast core needle biop- sies for gene expression microarray analyses. Clin. Cancer Res. 8(5):1155-1166. El-Masri, H.A., D.A. Bell, and C.J. Portier. 1999. Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans. Toxicol. Appl. Pharmacol. 158(3):221-230.

OCR for page 213
223 References Eng, J.K., A.L. McCormack, and J.R.Yates III. 1994. An approach to correlate tandem mass spectra data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5(11):976-989. EPA (U.S. Environmental Protection Agency). 1986. Guidelines for Carcinogen Risk Assessment. EPA/630/R-00/004. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC. EPA (U.S. Environmental Protection Agency). 2002. Interim Genomics Policy (June 25, 2002). Science Policy Council, U.S. Environmental Protection Agency [online]. Available: http://www.epa.gov/osa/spc/genomics.htm [accessed Nov. 14, 2005]. EPA (U.S. Environmental Protection Agency). 2003. Exposure and Human Health Reas- sessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Com- pounds. NAS Review Draft. National Center for Environmental Assessment, Of- fice of Research and Development, U.S. Environmental Protection Agency, Washington, DC. December 2003 [online]. Available: http://www.epa.gov/ncea/ pdfs/dioxin/nas-review/ [accessed Aug. 29, 2006]. EPA (U.S. Environmental Protection Agency). 2004. Potential Implications of Genomics for Regulatory and Risk Assessment Applications at EPA. EPA 100/B-04/002. Genomics Task Force Workgroup, Science Policy Council, U.S. Environmental Protection Agency, Washington, DC. December 2004 [online]. Available: http://www.epa.gov/osa/pdfs/EPA-Genomics-White-Paper.pdf [accessed Nov. 28, 2005]. EPA (U.S. Environmental Protection Agency). 2006a. The HPV Voluntary Challenge Chemical List. U.S. Environmental Protection Agency [online]. Available: http://www.epa.gov/chemrtk/pubs/update/hpvchmlt.htm [accessed May 1, 2007]. EPA (U.S. Environmental Protection Agency). 2006b. TSCA Regulations. Civil En- forcement, U.S. Environmental Protection Agency [online]. Available: http:// www.epa.gov/compliance/civil/tsca/tscaenfstatreq.html#regs [accessed May 1, 2007]. Famili, I., R. Mahadevan, and B.O. Palsson. 2005. k-Cone analysis: Determining all can- didate values for kinetic parameters on a network scale. Biophys. J. 88(3):1616- 1625. Farber, D.A. 1987. Toxic causation. Minn. L. Rev. 71:1219-1261. FDA (Food and Drug Administration). 2005a. Guidance for Industry: Pharmacogenomic Data Submissions. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biolog- ics Evaluation and Research, Center for Devices and Radiological Health. March 2005 [online]. Available: http://www.fda.gov/cber/gdlns/pharmdtasub.htm [ac- cessed Feb. 3, 2006]. FDA (Food and Drug Administration). 2005b. Drug-Diagnostic Co-Development Con- cept Paper. U.S. Department of Health and Human Services, Food and Drug Ad- ministration. April 2005 [online]. Available: http://www.fda.gov/cder/genomics/ pharmacoconceptfn.pdf [accessed Feb. 10, 2006]. Fella, K., M. Gluckmann, J. Hellmann, M. Karas, P.J. Kramer, and M. Kroger. 2005. Use of two-dimensional gel electrophoresis in predictive toxicology: Identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis. Proteomics 5(7):1914-1927. Fenyo, D. 2000. Identifying the proteome: Software tools. Curr. Opin. Biotechnol. 1(4):391-395.

OCR for page 213
244 Applications of Toxicogenomic Technologies Saal, L.H., C. Troein, J. Vallon-Christersson, S. Gruvberger, A. Borg, and C. Peterson. 2002. BioArray Software Environment (BASE): A platform for comprehensive management and analysis of microarray data. Genome Biol. 3(8):SOFTWARE 0003. Sadygov, R.G., D. Cociorva, and J.R. Yates III. 2004. Large-scale database searching using tandem mass spectra: Looking up the answer in the back of the book. Nat. Methods 1(3):195-202. Saeed, A.I., V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Klapa, T. Currier, M. Thiagarajan, A. Sturn, M. Snuffin, A. Rezantsev, D. Popov, A. Ryltsov, E. Kostukovich, I. Borisovsky, Z. Liu, A. Vinsavich, V. Trush, and J. Quackenbush. 2003. TM4: A free, open-source system for microarray data man- agement and analysis. Biotechniques 34(2):374-378. Safe, S. 1990. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). CRC Crit. Rev. Toxicol. 21(1):51-88. Said, M.R., T.J. Begley, A.V. Oppenheim, D.A. Lauffenburger, and L.D. Samson. 2004. Global network analysis of phenotypic effects: Protein networks and toxicity modulation in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 101(52): 18006-18011. Salerno, R.A., and L.J. Lesko. 2004. Pharmacogenomics in Drug Development and Regulatory Decision-making: The Genomic Data Submission (GDS) Proposal. Pharmacogenomics 5(1):25-30. Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74(12):5463-5467. Sansone, S.A., N. Morrison, P. Rocca-Serra, and J. Fostel. 2004. Standardization initia- tives in the (eco)toxicogenomics domain: A review. Comp. Funct. Genomics 5(8):633-641. Saul, S. 2005. U.S. to Review Drug Intended for One Race. N.Y. Times, P.1. June 13, 2005. Savoie, C.J., S. Aburatani, S. Watanabe, Y. Eguchi, S. Muta, S. Imoto, S. Miyano, S. Kuhara, and K. Tashiro. 2003. Use of gene networks from full genome microarray libraries to identify functionally relevant drug-affected genes and gene regulation cascades. DNA Res. 10(1):19-25. Sawada, H., K. Takami, and S. Asahi. 2005. A toxicogenomic approach to drug-induced phospholipidosis: Analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol. Sci. 83(2):282-292. Scarano, M.I., M. Strazzullo, M.R. Matarazzo, and M. D'Esposito. 2005. DNA methyla- tion 40 years later: Its role in human health and disease. J. Cell Physiol. 204(1):21- 35. Schadt, E.E., C. Li, B. Ellis, and W.H. Wong. 2001. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J. Cell Biochem. (Suppl 37):120-125. Schechtman, L.M. 2005. Toxicogenomics: ICCVAM Fundamentals for Validation and Regulatory Acceptance. Presentation at NAS Workshop onValidation of Toxico- genomic Technologies: A Focus on Chemical Classification Strategies, July 7-8, 2005, Washington, DC. Schena, M., D. Shalon, R.W. Davis, and P.O. Brown. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270(5235):467-470.

OCR for page 213
245 References Schena, M., D. Shalon, R. Heller, A. Chai, P.O. Brown, and R.W. Davis. 1996. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. U.S.A. 93(20):10614-10619. Schubert, E.L., L. Hsu, L.A. Cousens, J. Glogovac, S. Self, B.J. Reid, P.S. Rabinovitch, and P.L. Porter. 2002. Single nucleotide polymorphism array analysis of flow- sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer. Am. J. Pathol. 160(1):73-79. Searfoss, G.H., W.H. Jordan, D.O. Calligaro, E.J. Galbreath, L.M. Schirtzinger, B.R. Berridge, H. Gao, M.A. Higgins, P.C. May, and T.P. Ryan. 2003. Adipsin, a bio- marker of gastrointestinal toxicity mediated by a functional gamma-secretase in- hibitor. J. Biol. Chem. 278(46):46107-46116. Searle, S., and J.M. Blackwell. 1999. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J. Med. Genet. 36(4):295-299. Searfoss, G.H., Jordan, W.H., Calligaro, D.O., Galbreath, E.J., Schirtzinger, L.M., Ber- ridge, B.R., Gao, H., Higgins, M.A., May, P.C., and Ryan, T.P. 2003. Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional -Secretase In- hibitor. J. Biol. Chem. 278:46107-46116. Sen, B., A. Wang, S.D. Hester, JL. Robertson, and D.C. Wolf. 2005. Gene expression profiling of responses to dimethylarsinic acid in female F344 rat urothelium. Toxi- cology 215(3):214-226. Shannon, P., A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang, D. Ramage, N. Amin, B. Schwikowski, and T. Ideker. 2003. Cytoscape: A software environment for inte- grated models of biomolecular interaction networks. Genome Res. 13(11):2498- 2504. Shaw, M.A., D. Clayton, S.E. Atkinson, H. Williams, N. Miller, D. Sibthorpe, and J.M. Blackwell. 1996. Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J. Med. Genet. 33(8):672-677. Shendure, J., G.J. Porreca, N.B. Reppas, X. Lin, J.P. McCutcheon, A.M. Rosenbaum, M.D. Wang, K. Zhang, R.D. Mitra, and G.M. Church. 2005. Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309(5741):1728-1732. Shiloh, S. 1996. Decision-making in the context of genetic risk. Pp. 82-103 in The Trou- bled Helix: Social and Psychological Implications of the New Human Genetics, T. Marteau, and M. Richards, eds. Cambridge: Cambridge University Press. Shingara, J., K. Keiger, J. Shelton, W. Laosinchai-Wolf, P. Powers, R. Conrad, D. Brown, and E. Labourier. 2005. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 11(9):1461-1470. Shippy, R., T.J. Sendera, R. Lockner, C. Palaniappan, T. Kaysser-Kranich, G. Watts, and J. Alsobrook. 2004. Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations. BMC Genomics 5(1):61. Shmulevich, I., E.R. Dougherty, S. Kim, and W. Zhang. 2002a. Probabilistic Boolean Networks: A rule-based uncertainty model for gene regulatory networks. Bioin- formatics 18(2):261-274. Shmulevich, I., E.R. Dougherty, and W. Zhang. 2002b. Gene perturbation and interven- tion in probabilistic Boolean networks. Bioinformatics 18(10):1319-1331. Shugart, L., J.M. Holland, and R.O. Rahn. 1983. Dosimetry of PAH skin carcinogenesis: Covalent binding of benzo[a]pyrene to mouse epidermal DNA. Carcinogenesis 4(2):195-198.

OCR for page 213
246 Applications of Toxicogenomic Technologies Shukla, S.J., and M.E. Dolan. 2005. Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies. Pharmacogenomics 6(3):303-310. Sidransky, D., R. Irizarry, J.A. Califano, X. Li, H. Ren, N. Benoit, and L. Mao. 2003. Serum protein MALDI profiling to distinguish upper aerodigestive tract cancer pa- tients from control subjects. J. Natl. Cancer Inst. 95(22):1711-1717. Silver, L.M. 1995. Mouse Genetics: Concepts and Applications. New York: Oxford Uni- versity Press. Simon, R., M.D. Radmacher, and K. Dobbin. 2002. Design of studies using DNA mi- croarrays. Genet. Epidemiol. 23(1):21-36. Simon, R., M.D. Radmacher, K. Dobbin, and L.M. McShane. 2003. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J. Natl. Cancer. Inst. 95(1):14-18. Skipper, P.L., X. Peng, C.K. Soohoo, and S.R. Tannenbaum. 1994. Protein adducts as biomarkers of human carcinogen exposure. Drug Metab. Rev. 26(1-2):111-124. SMD. 2006. Stanford MicroArray Database. Departments of Biochemistry and Genetics at the School of Medicine, Stanford University [online]. Available: http://genome- www5.stanford.edu/ [accessed Aug. 24, 2006]. Smith, D., B.D. Collins, J. Heil, and T.H. Koch. 2003. Sensitivity and specificity of photoaptamer probes. Mol. Cell. Proteomics 2(1):11-18. Smith, R.D. 2002. Trends in mass spectrometry instrumentation for proteomics. Trends Biotechnol. 20(Suppl. 12):S3-S7. Soinov, L.A. 2003. Supervised classification for gene network reconstruction. Biochem. Soc. Trans. 31(Pt 6):1497-1502. Sorenson, J.R., and B. Cheuvront. 1993. The Human Genome Project and health behavior and health education research. Health Educ. Res. 8(4):589-593. Soukas, A., P. Cohen, N.D. Socci, and J.M. Friedman. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes. Dev. 14(8):963-980. Spellman, P.T., M. Miller, J. Stewart, C. Troup, U. Sarkans, S. Chervitz, D. Bernhart, G. Sherlock, C. Ball, M. Lepage, M. Swiatek, W.L. Marks, J. Goncalves, S. Markel, D. Iordan, M. Shojatalab, A. Pizarro, J. White, R. Hubley, E. Deutsch, M. Senger, B.J. Aronow, A. Robinson, D. Bassett, C.J. Stoeckert, Jr., and A. Brazma. 2002. Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol. 3(9):RESEARCH0046. Stahl, D.C., K.M. Swiderek, M.T. Davis, and T.D. Lee. 1996. Data-controlled automation of liquid chromatography/tandem mass spectrometry analysis of peptide mixtures. J. Am. Soc. Mass Spectrom. 7(6):532-540. Stearman, R.S., L. Dwyer-Nield, L. Zerbe, S.A. Blaine, Z. Chan, P.A. Bunn, Jr., G.L. Johnson, F.R. Hirsch, D.T. Merrick, W.A. Franklin, A.E. Baron, R.L. Keith, R.A. Nemenoff, A.M. Malkinson, and M.W. Geraci. 2005. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen- induced murine model. Am. J. Pathol. 167(6):1763-1775. Steiner, G., L. Suter, F. Boess, R. Gasser, M.C. de Vera, S. Albertini, and S. Ruepp. 2004. Discriminating different classes of toxicants by transcript profiling. Environ. Health Perspect. 112(12):1236-1248. Stoyanova, R., J.K. Nicholson, J.C. Lindon, and T.R. Brown. 2004. Sample classification based on Bayesian spectral decomposition of metabonomic NMR data sets. Anal. Chem. 76(13):3666-3674. Stribinskis, V., and K.S. Ramos. 2006. Activation of human long interspersed nuclear element 1 retrotransposition by benzo(a)pyrene, an ubiquitous environmental car- cinogen. Cancer Res. 66(5):2616-2620.

OCR for page 213
247 References Strouse, D.S. 2005. Informed consent to genetic research on banked human tissue. Juri- metrics 45:135-152. Stuart, J.M., E. Segal, D. Koller, and S.K. Kim. 2003. A gene-coexpression network for global discovery of conserved genetic modules. Science 302(5643):249-255. Suchard, M.A., P. Yudkin, and J.S. Sinsheimer. 1999. Are general practitioners willing and able to provide genetic services for common diseases? J. Genet. Couns. 8(5):301-311. Sun, Y.V., D.R. Boverhof, L.D. Burgoon, M.R. Fielden, and T.R. Zacharewski. 2004. Comparative analysis of dioxin response elements in human, mouse and rat ge- nomic sequences. Nucl. Acids Res. 32(15):4512-4523. Suter, L., M. Haiker, M.C. De Vera, and S. Albertini. 2003. Effect of two 5-HT6 receptor antagonists on the rat liver: A molecular approach. Pharmacogenomics J. 3(6):320- 334. Suter, L., L.E. Babiss, and E.B. Wheeldon. 2004. Toxicogenomics in predictive toxicol- ogy in drug development. Chem. Biol. 11(2):161-171. Sutherland, J.E., and M. Costa. 2003. Epigenetics and the environment. Ann. N.Y. Acad. Sci. 983:151-160. Sweet-Cordero, A., S. Mukherjee, A. Subramanian, H. You, J.J. Roix, C. Ladd-Acosta, J. Mesirov, T.R. Golub, and T. Jacks. 2005. An oncogenic KRAS2 expression signa- ture identified by cross-species gene-expression analysis. Nat. Genet. 37(1):48-55. Syka, J.E., J.A. Marto, D.L. Bai, S. Horning, M.W. Senko, J.C. Schwartz, B. Ueberheide, B. Garcia, S. Busby, T. Muratore, J. Shabanowitz, and D.F. Hunt. 2004a. Novel linear quadrupole ion trap/FT mass spectrometer: Performance characterization and use in the comparative analysis of histone H3 post-translational modifications. J. Proteome Res. 3(3):621-626. Syka, J.E., J.J. Coon, M.J. Schroeder, J. Shabanowitz, and D.F. Hunt. 2004b. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl. Acad. Sci. USA 101(26):9528-9533. Syvanen, A.C. 2005. Toward genome-wide SNP genotyping. Nat. Genet. 37 (Suppl.):S5- S10. Tamada, Y., S. Kim, H. Bannai, S. Imoto, K. Tashiro, S. Kuhara, and S. Miyano. 2003. Estimating gene networks from gene expression data by combining Bayesian net- work model with promoter element detection. Bioinformatics 19(Suppl. 2):II227- II236. Tamayo, P., D. Slonim, J. Mesirov, Q. Zhu, S. Kitareewan, E. Dmitrovsky, E.S. Lander, and T.R. Golub. 1999. Interpreting patterns of gene expression with self- organizing maps: Methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. USA 96(6):2907-2912. Tan, P.K., T.J. Downey, E.L. Spitznagel, Jr., P. Xu, D. Fu, D.S. Dimitrov, R.A. Lempicki, B.M. Raaka, and M.C. Cam. 2003. Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res. 31(19):5676-5684. Taylor, C.F., N.W. Paton, K.L. Garwood, P.D. Kirby, D.A. Stead, Z. Yin, E.W. Deutsch, L. Selway, J. Walker, I. Riba-Garcia, S. Mohammed, M.J. Deery, J.A. Howard, T. Dunkley, R. Aebersold, D.B. Kell, K.S. Lilley, P. Roepstorff, J.R. Yates III, A. Brass, A.J. Brown, P. Cash, S.J. Gaskell, S.J. Hubbard, and S.G. Oliver. 2003. A systematic approach to modeling, capturing, and disseminating proteomics ex- perimental data. Nat. Biotechnol. 21(3):247-254.

OCR for page 213
248 Applications of Toxicogenomic Technologies Tennant, R.W. 2002. The National Center for Toxicogenomics: Using new technologies to inform mechanistic toxicology [editorial]. Environ. Health Perspect.110(1):A8- A10. Teuschler, L., J. Klaunig, E. Carney, J. Chambers, R. Conolly, C. Gennings, J. Giesy, R. Hertzberg, C. Klaassen, R. Kodell, D. Paustenbach, and R. Yang. 2002. Support of science-based decisions concerning the evaluation of the toxicology of mixtures: A new beginning. Regul. Toxicol. Pharmacol. 36(1):34-39. Thackaberry, E.A., Z. Jiang, C.D. Johnson, K.S. Ramos, and M.K. Walker. 2005. Toxi- cogenomic profile of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the murine fetal heart: Modulation of cell cycle and extracellular matrix genes. Toxicol. Sci. 88(1):231- 241. Theilhaber, J., T. Connolly, S. Roman-Roman, S. Bushnell, A. Jackson, K. Call, T. Garcia, and R. Baron. 2002. Finding genes in the C2C12 osteogenic pathway by k- nearest-neighbor classification of expression data. Genome Res. 12(1):165-176. Thomas, D.B., D.L. Gao, S.G. Self, C.J. Allison, Y. Tao, J. Mahloch, R. Ray, Q. Qin, R. Presley, and P. Porter. 1997. Randomized trial of breast self-examination in Shanghai: Methodology and preliminary results. J. Natl. Cancer Inst. 89(5):355- 365. Thomas, R.S., D.R. Rank, S.G. Penn, G.M. Zastrow, K.R. Hayes, K. Pande, E. Glover, T. Silander, M.W. Craven, J.K. Reddy, S.B. Jovanovich, and C.A. Bradfield. 2001. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 60(6):1189-1194. Thompson, K.L., C.A. Afshari, R.P. Amin, T.A. Bertram, B. Car, M. Cunningham, C. Kind, J.A. Kramer, M. Lawton, M. Mirsky, J.M. Naciff , V. Oreffo, P.S. Pine, and F.D. Sistare. 2004. Identification of platform-independent gene expression markers of cisplatin nephrotoxicity. Environ. Health Perspect. 112(4):488-494. Thorgeirsson, S.S., J.S. Lee, and J.W. Grisham. 2006. Functional genomics of hepatocel- lular carcinoma. Hepatology 43(2 Suppl. 1):S145-S150. Thukral, S.K., P.J. Nordone, R. Hu, L. Sullivan, E. Galambos, V.D. Fitzpatrick, L. Healy, M.B. Bass, M.E. Cosenza, and C.A. Afshari. 2005. Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Toxicol. Pathol. 33(3):343-355. Timchalk, C., A. Kousba, and T. S. Poet. 2002. Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based phar- macokinetic and pharmacodynamic (PBPK/PD) model. Toxicol. Lett. 135(1-2):51- 59. Todd, J.A., T.J. Aitman, R.J. Cornall, S. Ghosh, J.R. Hall, C.M. Hearne, A.M. Knight, J.M. Love, M.A. McAleer, J.B. Prins, M. Rodriguez, A. Lathrop, A. Pressey, N.H. DeLarato, L.B. Peterson, and L.S. Wicker. 1991. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 351(6327):542-547. Tonge, R., J. Shaw, B. Middleton, R. Rowlinson, S. Rayner, J. Young, F. Pognan, E. Hawkins, I. Currie, and M. Davison. 2001. Validation and development of fluores- cence two-dimensional differential gel electrophoresis proteomics technology. Pro- teomics 1(3):377-396. Toronen, P., M. Kolehmainen, G. Wong, and E. Castren. 1999. Analysis of gene expres- sion data using self-organizing maps. FEBS Lett. 451(2):142-146. TRC (Toxicogenomics Research Consortium). 2003. TRC Member Publications. Toxi- cogenomics Research Consortium. Division of Extramural Research and Training, National Institute of Environmental Health Sciences [online]. Available: http:// www.niehs.nih.gov/dert/trc/pub-mem.htm [accessed May 9, 2007].

OCR for page 213
249 References TRC (Toxicogenomics Research Consortium). 2005. Toxicogenomics Research Consor- tium. Division of Extramural Research and Training, National Institute of Envi- ronmental Health Sciences [online]. Available: http://www.niehs.nih.gov/dert/trc/ home.htm [accessed Feb. 28, 2006]. Tusher, V.G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays ap- plied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98(9):5116- 5121. UK Biobank Limited. 2007. Biobank: Improving the Health of Future Generation [online]. Available: http://www.ukbiobank.ac.uk/ [accessed Sept. 28, 2007]. Ulrich, R., and S.H. Friend. 2002. Toxicogenomics and drug discovery: Will new tech- nologies help us produce better drugs? Nat. Rev. Drug Discov. 1(1):84-88. Ulrich, R.G., J.C. Rockett, G.G. Gibson, and S.D. Pettit. 2004. Overview of an interlabo- ratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression. Environ. Health Perspect. 112(4):423-427. Urushidani, T., and T. Nagao. 2005. Toxicogenomics: Japanese initiative. Pp. 623-631 in Handbook of Toxicogenomics: Strategies and Applications, J. Borlak, ed. Wein- heim: Wiley-VCH. UW-Madison (University of Wisconsin at Madison). 2006. Edge2: The Environment, Drugs and Gene Expression. Bradfield Laboratory, University of Wisconsin at Madison [online]. Available: http://edge.oncology.wisc.edu/edge.php [accessed May 9, 2007]. Uzumcu, M., H. Suzuki, and M.K. Skinner. 2004. Effect of the anti-androgenic endocrine disruptor vinclozolin on embryonic testis cord formation and postnatal testis de- velopment and function. Reprod. Toxicol. 18(6):765-774. van Delft, J.H., E. van Agen, S.G. van Breda, M.H. Herwijnen, Y.C. Staal, and J.C. Kleinjans. 2005. Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. Mutat. Res. 575(1-2):17-33. van de Peppel, J., P. Kemmeren, H. van Bakel, M. Radonjic, D. van Leenen, F.C. Holstege. 2003. Monitoring global messenger RNA changes in externally con- trolled microarray experiments. EMBO Rep. 4(4):387-393. van de Vijver, M.J., Y.D. He, L.J. van't Veer, H. Dai, A.A. Hart, D.W. Voskuil, G.J. Schreiber, J.L. Peterse, C. Roberts, M.J. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, T. van der Velde, H. Bartelink, S. Rodenhuis, E.T. Rutgers, S.H. Friend, and R. Bernards. 2002. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347(25):1999-2009. van de Waterbeemd, H., and E. Gifford. 2003. ADMET in silico modelling: Towards prediction paradise? Nat. Rev. Drug Discov. 2(3):192-204. van Leeuwen, A., P.I. Schrier, M.J. Giphart, I.A. Noordermeer, D.J. Ruiter, P. Rubin- stein, and J.J. van Rood. 1986. TCA: A polymorphic genetic marker in leukemias and melanoma cell lines. Blood 67(4):1139-1142. van 't Veer, L.J., H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, A.T. Witteveen, G.J. Schreiber, R.M. Kerkhoven, C. Roberts, P.S. Linsley, R. Bernards, and S.H. Friend. 2002. Gene expression pro- filing predicts clinical outcome of breast cancer. Nature 415(6871):530-536. Venter, J.C., H.O. Smith, and L. Hood. 1996. A new strategy for genome sequencing. Nature 381(6581):364-366. Vezina, C.M., N.J. Walker, and J.R. Olson. 2004. Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: Effect on hepatic gene expression. Environ. Health Perspect. 112(16):1636-1644.

OCR for page 213
250 Applications of Toxicogenomic Technologies Villanueva, J., J. Philip, D. Entenberg, C.A. Chaparro, M.K. Tanwar, E.C. Holland, and P. Tempst. 2004. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal. Chem. 76(6):1560- 1570. Von Eggeling, F., A. Gawriljuk, W. Fiedler, G. Ernst, U. Claussen, J. Klose, and I. Ro- mer. 2001. Fluorescent dual colour 2D-protein gel electrophoresis for rapid detec- tion of differences in protein pattern with standard image analysis software. Int. J. Mol. Med. 8(4):373-377. Wagner, J.A. 2002. Overview of biomarkers and surrogate endpoints in drug develop- ment. Dis. Markers 18(2):41-46. Walum, E., J. Hedander, and P. Garberg. 2005. Research perspectives for pre-screening alternatives to animal experimentation on the relevance of cytotoxicity measure- ments, barrier passage determinations and high throughput screening in vitro to se- lect potentially hazardous compounds in large sets of chemicals. Toxicol. Appl. Pharmacol. 207(2 Suppl.):393-397. Wang, C., R. Gonzalez, and S.D. Merajver. 2004. Assessment of genetic testing and re- lated counseling services: Current research and future directions. Soc. Sci. Med. 58(7):1427-1442. Wang, C., D.J. Bowen, and S.L. Kardia. 2005. Research and practice opportunities at the intersection of health education, health behavior, and genomics. Health Educ. Be- hav. 32(5):686-701. Wang, H.T., J.P. Kong, F. Ding, X.Q. Wang, M.R. Wang, L.X. Liu, M. Wu, and Z.H. Liu. 2003. Analysis of gene expression profile induced by EMP-1 in esophageal cancer cells using cDNA Microarray. World J. Gastroenterol. 9(3):392-398. Wang, J., J. Delabie, H. Aasheim, E. Smeland, and O. Myklebost. 2002. Clustering of the SOM easily reveals distinct gene expression patterns: Results of a reanalysis of lymphoma study. BMC Bioinformatics 3(1):36. Wang, W., H. Zhou, H. Lin, S. Roy, T.A. Shaler, L.R. Hill, S. Norton, P. Kumar, M. Anderle, and C.H. Becker. 2003. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem. 75(18):4818-4826. Wang, X., D.J. Tomso, X. Liu, and D.A. Bell. 2005. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicol. Appl. Pharmacol. 207(Suppl. 2):S84-S90. Wang, Y., M.E. Bollard, H. Keun, H. Antti, O. Beckonert, T.M. Ebbels, J.C. Lindon, E. Holmes, H. Tang, and J.K. Nicholson. 2003. Spectral editing and pattern recogni- tion methods applied to high-resolution magic-angle spinning 1H nuclear magnetic resonance spectroscopy of liver tissues. Anal. Biochem. 323(1):26-32. Wang, Y., J. Hayakawa, F. Long, Q. Yu, A.H. Cho, G. Rondeau, J. Welsh, S. Mittal, I. De Belle, E. Adamson, M. McClelland, and D. Mercola. 2005a. Promoter array studies identify cohorts of genes directly regulated by methylation, copy number change, or transcription factor binding in human cancer cells. Ann. N.Y. Acad. Sci. 1058:162-185. Wang, Y., H. Tang, J.K. Nicholson, P.J. Hylands, J. Sampson, and E. Holmes. 2005b. A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J. Agric. Food Chem. 53(2):191-196. Wang, Z., H. Fan, H.H. Yang, Y. Hu, K.H. Buetow, and M.P. Lee. 2004. Comparative sequence analysis of imprinted genes between human and mouse to reveal imprint- ing signatures. Genomics 83(3):395-401.

OCR for page 213
251 References Wang, Z., D. Neuburg, C. Li, L. Su, J.Y. Kim, J.C. Chen, and D.C. Christiani. 2005. Global gene expression profiling in whole-blood samples from individuals ex- posed to metal fumes. Environ. Health Perspect. 113(2):233-241. Waring, J.F., R.A. Jolly, R. Ciurlionis, P.Y. Lum, J.T. Praestgaard, D.C. Morfitt, B. Buratto, C. Roberts, E. Schadt, and R.G. Ulrich. 2001. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol. 175(1):28-42. Waring, J.F., R. Gum, D. Morfitt, R.A. Jolly, R. Ciurlionis, M. Heindel, L. Gallenberg, B. Buratto, and R.G. Ulrich. 2002. Identifying toxic mechanisms using DNA microar- rays: Evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor. Toxicology 181-182:537- 550. Waring, J.F., R.G. Ulrich, N. Flint, D. Morfitt, A. Kalkuhl, F. Staedtler, M. Lawton, J.M. Beekman, and L. Suter. 2004. Interlaboratory evaluation of rat hepatic gene ex- pression changes induced by methapyrilene. Environ. Health Perspect. 112(4):439- 448. Washburn, M.P., D. Wolters, and J.R. Yates III. 2001. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19(3):242-247. Washburn, M.P., R. Ulaszek, C. Deciu, D.M. Schieltz, and J.R. Yates III. 2002. Analysis of quantitative proteomic data generated via multidimensional protein identifica- tion technology. Anal. Chem. 74(7):1650-1657. Washington, HA. 1994. Henrietta Lacks: An unsung hero. Emerge (Oct.):29. Waterland, R.A., and R.L. Jirtle. 2004. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutri- tion 20(1):63-68. Waters, M., G. Boorman, P. Bushel, M. Cunningham, R. Irwin, A. Merrick, K. Olden, R. Paules, J. Selkirk, S. Stasiewicz, B. Weis, B. Van Houten, N. Walker, and R. Tennant. 2003b. Systems toxicology and the Chemical Effects in Biological Sys- tems (CEBS) knowledge base. EHP Toxicogenomics 111(1T):15-28. Waters, N.J, S. Garrod, R.D. Farrant, J.N. Haselden, S.C. Connor, J. Connelly, J.C. Lindon, E. Holmes, and J.K. Nicholson. 2000. High-resolution magic angle spin- ning (1)H NMR spectroscopy of intact liver and kidney: Optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisi- tion. Anal. Biochem. 282(1):16-23. Waters, N.J., E. Holmes, A. Williams, C.J. Waterfield, R.D. Farrant, and J.K. Nicholson. 2001. NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: An integrative metabonomic approach. Chem. Res. Toxicol. 14(10):1401-1412. Waters, N.J., E. Holmes, C.J. Waterfield, R.D. Farrant, and J.K. Nicholson. 2002. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate. Biochem. Pharmacol. 64(1):67-77. Waters, N.J., C.J. Waterfield, R.D. Farrant, E. Holmes, and J.K. Nicholson. 2005. Me- tabonomic deconvolution of embedded toxicity: Application to thioacetamide hepato- and nephrotoxicity. Chem. Res. Toxicol. 18(4):639-654. Weber, W.W. 1997. Pharmacogenetics. Oxford: Oxford University Press. Weijer, C., and P.B. Miller. 2004. Protecting communities in pharmacogenetic and phar- macogenomic research. Pharmacogenomics J. 4(1):9-16. Weinstein, J.N., T.G. Myers, P.M. O'Connor, S.H. Friend, A.J. Fornace Jr, K.W. Kohn, T. Fojo, S.E. Bates, L.V. Rubinstein, N.L. Anderson, J.K. Buolamwini, W.W. van

OCR for page 213
252 Applications of Toxicogenomic Technologies Osdol, A.P. Monks, D.A. Scudiero, E.A. Sausville, D.W. Zaharevitz, B. Bunow, V.N. Viswanadhan, G.S. Johnson, R.E. Wittes, and K.D. Paull. 1997. An informa- tion-intensive approach to the molecular pharmacology of cancer. Science 275(5298):343-349. Welch, K.D., B. Wen, D.R. Goodlett, E.C. Yi, H. Lee, T.P. Reilly, S.D. Nelson, and L.R. Pohl. 2005. Proteomic identification of potential susceptibility factors in drug- induced liver disease. Chem. Res. Toxicol. 18(6):924-933. Wen, X., S. Fuhrman, G.S. Michaels, D.B. Carr, S. Smith, J.L. Barker, and R. Somogyi. 1998. Large-scale temporal gene expression mapping of central nervous system development. Proc. Natl. Acad. Sci USA 95(1):334-339. Wesselkamper, S.C., L.M. Case, L.N. Henning, M.T. Borchers, J.W. Tichelaar, J.M. Mason, N. Dragin, M. Medvedovic, M.A. Sartor, C.R. Tomlinson, and G.D. Leikauf. 2005. Gene expression changes during the development of acute lung in- jury: Role of TGF-{beta}. Am. J. Respir. Crit. Care Med. 172(11):1399-1411. Weston, W.M., E.E. LeClair, W. Trzyna, K.M. McHugh, P. Nugent, C.M. Lafferty, L. Ma, R.S. Tuan, and R.M. Greene. 1999. Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung. J. Biol. Chem. 274(19):13698-13703. Wiback, S.J., R. Mahadevan, and B.O. Palsson. 2004. Using metabolic flux data to fur- ther constrain the metabolic solution space and predict internal flux patterns: The Escherichia coli spectrum. Biotechnol. Bioeng. 86(3):317-331. Wilkinson, C.F., G.R. Christoph, E. Julien, J.M. Kelley, J. Kronenberg, J. McCarthy, and R. Reiss. 2000. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: How to cumulate? Regul. Toxicol. Pharmacol. 31(1):30-43. Williams, R.E., H. Major, E.A. Lock, E.M. Lenz, and I.D. Wilson. 2005. D-Serine- induced nephrotoxicity: A HPLC-TOF/MS-based metabonomics approach. Toxi- cology 207(2):179-190. Wilson, I.D., and J.K. Nicholson. 2003. Topics in xenobiochemistry: Do metabolic path- ways exist for xenobiotics? The micro-metabolism hypothesis. Xenobiotica 33(9):887-901. Wilson, I.D., R. Plumb, J. Granger, H. Major, R. Williams, and E.M. Lenz. 2005a. HPLC-MS-based methods for the study of metabonomics. J. Chromatogr. B Ana- lyt. Technol. Biomed. Life Sci. 817(1):67-76. Wilson, I.D., J.K. Nicholson, J. Castro-Perez, J.H. Granger, K.A. Johnson, B.W. Smith, and R.S. Plumb. 2005b. High resolution “ultra performance” liquid chromatogra- phy coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res. 4(2):591-598. Wiltse, J. 2005. Mode of action: Inhibition of histone deacetylase, altering WNT- dependent gene expression, and regulation of beta-catenin – developmental effects of valproic acid. Crit. Rev. Toxicol. 35(8-9):727-738. Witte, K. 1994. Fear control and danger control: A test of the Extended Parallel Process Model (EPPM). Commun. Monogr. 61(2):113-134. Wolpert, D.H., and W.G. MacReady. 1997. No free lunch theorems for optimization, IEEE T. Evolut. Comput. 1(1):67-82. Wolters, D.A., M.P. Washburn, and J.R.Yates, III. 2001. An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73(23): 5683-5690.

OCR for page 213
253 References Workman, C.T., H.C. Mak, S. McCuine, J.B. Tagne, M. Agarwal, O. Ozier, T.J. Begley, L.D. Samson, and T. Ideker. 2006. A systems approach to mapping DNA damage response pathways. Science 312(5776):1054-1059. Wu, M.T., B. Demple, R.A. Bennett, D.C. Christiani, R. Fan, and H. Hu. 2000. Individ- ual variability in the zinc inducibility of metallothionein-IIA mRNA in human lymphocytes. J. Toxicol. Environ. Health A 61(7):553-567. Wu, S.L., J. Kim, W.S. Hancock, and B. Karger. 2005. Extended Range Proteomic Analysis (ERPA): A new and sensitive LC-MS platform for high sequence cover- age of complex proteins with extensive post-translational modifications- comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR). J. Proteome Res. 4(4):1155-1170. Xenarios, I., L. Salwinski, X.J. Duan, P. Higney, S.M. Kim, and D. Eisenberg. 2002. DIP, the Database of Interacting Proteins: A research tool for studying cellular networks of protein interactions. Nucleic Acids Res. 30(1):303-305. Xiao, G.G., M. Wang, N. Li, J.A. Loo, and A.E. Nel. 2003. Use of proteomics to demon- strate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J. Biol. Chem. 278(50):50781-50790. Xu, X.Q., C.K. Leow, X. Lu, X. Zhang, J.S. Liu, W.H. Wong, A. Asperger, S. Deininger, and H.C. Eastwood Leung. 2004. Molecular classification of liver cirrhosis in a rat model by proteomics and bioinformatics. Proteomics 4(10):3235-3245. Yamamoto, T., R. Kikkawa, H. Yamada, and I. Horii. 2005. Identification of oxidative stress-related proteins for predictive screening of hepatotoxicity using a proteomic approach. J. Toxicol. Sci. 30(3):213-227. Yang, I., I.Y. Park, S.M. Jang, L.H. Shi, H.K. Ku, and S.R. Park. 2006. Rapid quantifica- tion of DNA methylation through dNMP analysis following bisulfite-PCR. Nucleic Acids Res. 34(8):e61. Yang, I.V., E. Chen, J.P. Hasseman, W. Liang, B.C. Frank, S. Wang, V. Sharov, A.I. Saeed, J. White, J. Li, N.H. Lee, T.J. Yeatman, and J. Quackenbush. 2002. Within the fold: Assessing differential expression measures and reproducibility in mi- croarray assays. Genome Biol. 3(11):RESEARCH0062. Yang, R.S.H. 1994. Toxicology of Chemical Mixtures: Case Studies, Mechanisms, and Novel Approaches. San Diego: Academic Press. Yang, Y.H., S. Dudoit, P. Luu, D.M. Lin, V. Peng, J. Ngai, and T.P. Speed. 2002. Nor- malization for cDNA microarray data: A robust composite method addressing sin- gle and multiple slide systematic variation. Nucleic Acids Res. 30(4):e15. Yao, G., M. Craven, N. Drinkwater, and C.A. Bradfield. 2004. Interaction networks in yeast define and enumerate the signaling steps or the vertebrate aryl hydrocarbon receptor. PloS Biol. 2(3):E65. Yates, J.R. III. 1998. Mass spectrometry and the age of the proteome. J. Mass. Spectrom. 33(1):1-19. Yates, J.R. III. 2000. Mass spectrometry: From genomics to proteomics. Trends Genet. 16(1):5-8. Yauk, C.L., M.L. Berndt, A. Williams, and G.R. Douglas. 2004. Comprehensive com- parison of six microarray technologies. Nucleic Acids Res. 32(15):e124. Yuen, T., E. Wurmbach, R.L. Pfeffer, B.J. Ebersole, and S.C. Sealfon. 2002. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res. 30(10):E48. Yuk, J.S., and K.S. Ha. 2005. Proteomic applications of surface plasmon resonance bio- sensors: Analysis of protein arrays. Exp. Mol. Med. 37(1):1-10.

OCR for page 213
254 Applications of Toxicogenomic Technologies Yuk, J.S., S.H. Jung, J.W. Jung, D.G. Hong, J.A. Han, Y.M. Kim, and K.S. Ha. 2004. Analysis of protein interactions on protein arrays by a wavelength interrogation- based surface plasmon resonance biosensor. Proteomics 4(11):3468-3476. Zarbl, H. 2001. DNA microarrays: An overview of technologies and applications to toxi- cology. Curr. Protocol. Toxicol. (Suppl. 9):1.4.2-1.4.16. Zeeberg, B.R., W. Feng, G. Wang, M.D. Wang, A.T. Fojo, M. Sunshine, S. Narasimhan, D.W. Kane, W.C. Reinhold, S. Lababidi, K.J. Bussey, J. Riss, J.C. Barrett, and J.N. Weinstein. 2003. GoMiner: A resource for biological interpretation of ge- nomic and proteomic data. Genome Biol. 4(4):R28. Zeiger, E. 2003. Validation and acceptance of new and revised tests: A flexible but trans- parent process. Toxicol. Lett. (140-141):31-35. Zhang, K., Z.S. Qin, J.S. Liu, T. Chen, M.S. Waterman, and F. Sun. 2004. Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies. Genome Res. 14(5):908-916. Zhou, H., J.A. Ranish, J.D. Watts, and R. Aebersold. 2002. Quantitative proteome analy- sis by solid-phase isotope tagging and mass spectrometry. Nat. Biotechnol. 20(5):512-515. Zhou, W., G. Liu, D.P. Miller, S.W. Thurston, L.L. Xu, J.C. Wain, T.J. Lynch, L. Su, and D.C. Christiani. 2003. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 12(4):359-365. Zhou, W., J.J. Ryan, and H. Zhou. 2004. Global analyses of sumoylated proteins in Sac- charomyces cerevisiae. Induction of protein sumoylation by cellular stresses. J. Biol. Chem. 279(31):32262-32268. Zhu, H., M. Bilgin, R. Bangham, D. Hall, A. Casamayor, P. Bertone, N. Lan, R. Jansen, S. Bidlingmaier, T. Houfek, T. Mitchell, P. Miller, R.A. Dean, M. Gerstein, and M. Snyder. 2001. Global analysis of protein activities using proteome chips. Sci- ence 293(5537):2101-2105. Zou, M., and S.D. Conzen. 2005. A new dynamic Bayesian network (DBN) approach for identifying gene regulatory networks from time course microarray data. Bioinfor- matics 21(1):71-79.